MedTrace Logo

Regional Nasal Block and Dexmedetomidine in Endoscopic Sinus Surgery

NCT05361642 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2022-09-02

No results posted yet for this study

Summary

The purpose is to compare the efficacy of combined regional nasal block and general anesthesia versus general anesthesia with dexmedetomidine during endoscopic sinus surgery in optimizing intraoperative surgical field.

Conditions

  • Drug Use

Interventions

DRUG

Bupivacaine HCl 0.5% Injectable Solution

using nasal block including sphenopalatine ganglion block with general anesthesia to optimize surgical field

DRUG

Dexmedetomidine

using dexmedetomidine with induction of general anesthesia to optimize surgical field

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Nahed Effat Yossef Salama, Professor · Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-02-03
Primary Completion
2022-11-05
Completion
2022-12-05

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05361642 on ClinicalTrials.gov